UBS Group
LH icon

UBS Group’s Labcorp LH Stock Holding History

UBS Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$57.4K – 10899
2025
Q3 		$57.4K Hold
200
– – ﹤0.01% 7469
2025
Q2 		$52.5K Hold
200
– – ﹤0.01% 7727
2025
Q1 		$46.5K Buy
+200
New +$48.5K ﹤0.01% 7647
2023
Q1 		– Sell
-116
Closed -$23.5K – 10014
2022
Q4 		$23.5K Sell
116
-117
-50% -$22.9K ﹤0.01% 7482
2022
Q3 		$41K Buy
+233
New +$47.7K ﹤0.01% 6544
2022
Q1 		– Sell
-233
Closed -$63K – 10612
2021
Q4 		$63K Buy
+233
New +$57.7K ﹤0.01% 6707
2021
Q1 		– Sell
-116
Closed -$20K – 9264
2020
Q4 		$20K Sell
116
-8,265
-99% -$1.43M ﹤0.01% 6944
2020
Q3 		$1.36M Buy
8,381
+8,265
+7,125% +$1.31M ﹤0.01% 3414
2020
Q2 		$17K Sell
116
-8,381
-99% -$1.16M ﹤0.01% 6659
2020
Q1 		$923K Buy
+8,497
New +$1.22M ﹤0.01% 3418

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group's LH Position: Q2 2026 in Review

UBS Group reduced its Labcorp (LH) stake by 8.6% in Q2 2026, selling an estimated $12.7M and leaving 516,070 shares worth $144M. The position accounts for 0.02% of the portfolio, ranked #878.

UBS Group first reported a position in LH in Q4 2014 and has held it in 47 quarters since. The position peaked at $151M in Q1 2026. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • UBS Group held 516,070 shares of Labcorp worth $144M as of Q2 2026.
  • UBS Group sold 48,459 Labcorp shares in Q2 2026, an estimated $12.7M.
  • Labcorp made up 0.02% of UBS Group's portfolio in Q2 2026, its #878 holding.
  • UBS Group first reported a position in Labcorp in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Labcorp position peaked at $151M in Q1 2026.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.